Scancell, which works to develop immunotherapies to treat cancer, has taken lab and office space at The Oxford Science Park (TOSP).

The firm which has 1,900 sq ft of labs at the Biodiscovery Institute at the University of Nottingham, has now taken an additional 1,800 sq ft at TOSP’s Bellhouse Building.

Scancell, which raised £46 million last year, employs more than 40 people and plans to increase numbers.

Scancell chief executive Prof Lindy Durrant said: “TOSP is the perfect location for Scancell’s expansion, with access to an excellent local talent pool as we grow the business.

“We are excited to be part of the creative and collaborative group of companies located in the park and look forward to further developing our innovative products at this new site.”

Chief executive of TOSP Rory Maw said: “With its leading research in cancer and infectious disease, the company is a great addition to the innovation community here. This is exciting news for TOSP, following the announcement of our partnership with GIC to accelerate development of the park.”

© Thames Tap (powered by

Sign up to receive your free weekly Thames Tap newsletter here.